Literature DB >> 17521693

JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease.

Thomas J Chambers1, Deborah A Droll, Xiaoshan Jiang, William S M Wold, Janice A Nickells.   

Abstract

A molecular clone of Japanese encephalitis (JE) virus Nakayama strain was used to create intertypic viruses containing either the 5'-C-prM-E or the prM-E region of the attenuated JE SA14-14-2 virus in the JE Nakayama background. These two intertypic JE viruses, JE-X/5'CprME(S) and JE-X/prME(S), respectively, generally resembled the parental JE virus in cell culture properties. Similar to virus derived from the JE Nakayama molecular clone (JE-XJN), JE-X/prME(S) was highly neuroinvasive and neurovirulent for young adult mice, whereas JE-X/5'CprME(S) was attenuated for neuroinvasiveness and only partially attenuated for neurovirulence. Immunization of young mice with JE-X/5'CprME(S) virus elicited neutralizing antibodies against JE Nakayama virus and conferred protection against encephalitis following challenge with JE Nakayama virus. The sequence of the JE-X/5'CprME(S) virus differed from that of JE-X/prME(S) virus at two nucleotides in the 5' UTR, 3 amino acid positions in the capsid protein, 4 positions in the prM protein and 1 in the envelope protein. For JE-X/prME(S) virus, the 4 differences in prM and the single substitution in the envelope represented reversions to the sequence of JE Nakayama virus. Overall, this study reveals that molecular determinants associated with the prM-E region of the attenuated JE SA14-14-2 virus are insufficient by themselves to confer an attenuation phenotype upon JE Nakayama virus. This suggests a role for determinants in the 5' UTR and/or the capsid protein of the JE SA 14-14-2 virus genome in influencing the virulence properties of the JE Nakayama virus in the mouse model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521693      PMCID: PMC2266982          DOI: 10.1016/j.virol.2007.04.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  36 in total

1.  Spontaneous mutations restore the viability of tick-borne encephalitis virus mutants with large deletions in protein C.

Authors:  Regina M Kofler; Agnes Leitner; Gabriel O'Riordain; Franz X Heinz; Christian W Mandl
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 2.  Japanese encephalitis.

Authors:  Scott B Halstead; Julie Jacobson
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

3.  SWISS-MODEL: An automated protein homology-modeling server.

Authors:  Torsten Schwede; Jürgen Kopp; Nicolas Guex; Manuel C Peitsch
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

4.  Conserved RNA secondary structures in Flaviviridae genomes.

Authors:  Caroline Thurner; Christina Witwer; Ivo L Hofacker; Peter F Stadler
Journal:  J Gen Virol       Date:  2004-05       Impact factor: 3.891

5.  Sequence and secondary structure analysis of the 5'-terminal region of flavivirus genome RNA.

Authors:  M A Brinton; J H Dispoto
Journal:  Virology       Date:  1988-02       Impact factor: 3.616

6.  Complete nucleotide sequence of the Japanese encephalitis virus genome RNA.

Authors:  H Sumiyoshi; C Mori; I Fuke; K Morita; S Kuhara; J Kondou; Y Kikuchi; H Nagamatu; A Igarashi
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

7.  Solution structure of dengue virus capsid protein reveals another fold.

Authors:  Lixin Ma; Christopher T Jones; Teresa D Groesch; Richard J Kuhn; Carol Beth Post
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

8.  Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use.

Authors:  K H Eckels; Y X Yu; D R Dubois; N J Marchette; D W Trent; A J Johnson
Journal:  Vaccine       Date:  1988-12       Impact factor: 3.641

9.  Fusion PCR generated Japanese encephalitis virus/dengue 4 virus chimera exhibits lack of neuroinvasiveness, attenuated neurovirulence, and a dual-flavi immune response in mice.

Authors:  Edward Gitau Matumbi Mathenge; Maria Del Carmen Parquet; Yasutomo Funakoshi; Seiji Houhara; Pooi Fong Wong; Akitoyo Ichinose; Futoshi Hasebe; Shingo Inoue; Kouichi Morita
Journal:  J Gen Virol       Date:  2004-09       Impact factor: 3.891

10.  Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2.

Authors:  S Nitayaphan; J A Grant; G J Chang; D W Trent
Journal:  Virology       Date:  1990-08       Impact factor: 3.616

View more
  12 in total

1.  Genetic and phenotypic properties of vero cell-adapted Japanese encephalitis virus SA14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice.

Authors:  Gregory D Gromowski; Cai-Yen Firestone; José Bustos-Arriaga; Stephen S Whitehead
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

2.  Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.

Authors:  Gregory D Gromowski; Cai-Yen Firestone; Stephen S Whitehead
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

3.  Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain.

Authors:  Amanda E Calvert; Kandice L Dixon; Mark J Delorey; Carol D Blair; John T Roehrig
Journal:  Vaccine       Date:  2013-11-17       Impact factor: 3.641

4.  Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers.

Authors:  Peter F Wright; Sharon Ankrah; Susan E Henderson; Anna P Durbin; Jim Speicher; Stephen S Whitehead; Brian R Murphy; Alexander G Pletnev
Journal:  Vaccine       Date:  2008-01-04       Impact factor: 3.641

5.  Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain.

Authors:  Jian Yang; Huiqiang Yang; Zhushi Li; Wei Wang; Hua Lin; Lina Liu; Qianzhi Ni; Xinyu Liu; Xianwu Zeng; Yonglin Wu; Yuhua Li
Journal:  Viruses       Date:  2017-01-21       Impact factor: 5.048

6.  Phenotypic and Genotypic Comparison of a Live-Attenuated Genotype I Japanese Encephalitis Virus SD12-F120 Strain with Its Virulent Parental SD12 Strain.

Authors:  Muhammad Naveed Anwar; Xin Wang; Muddassar Hameed; Abdul Wahaab; Chenxi Li; Mona Sharma; Linlin Pang; Muhammad Irfan Malik; Ke Liu; Beibei Li; Yafeng Qiu; Jianchao Wei; Zhiyong Ma
Journal:  Viruses       Date:  2020-05-16       Impact factor: 5.048

7.  Japanese encephalitis virus neuropenetrance is driven by mast cell chymase.

Authors:  Justin T Hsieh; Abhay P S Rathore; Gayathri Soundarajan; Ashley L St John
Journal:  Nat Commun       Date:  2019-02-11       Impact factor: 14.919

8.  Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2.

Authors:  Shi-Hua Li; Xiao-Feng Li; Hui Zhao; Yong-Qiang Deng; Xue-Dong Yu; Shun-Ya Zhu; Tao Jiang; Qing Ye; E-De Qin; Cheng-Feng Qin
Journal:  Virol J       Date:  2013-02-26       Impact factor: 4.099

9.  C19orf66 Inhibits Japanese Encephalitis Virus Replication by Targeting -1 PRF and the NS3 Protein.

Authors:  Du Yu; Yundi Zhao; Junhui Pan; Xingmiao Yang; Zhenjie Liang; Shengda Xie; Ruibing Cao
Journal:  Virol Sin       Date:  2021-07-26       Impact factor: 6.947

10.  A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice.

Authors:  Sang-Im Yun; Byung-Hak Song; Jin-Kyoung Kim; Gil-Nam Yun; Eun-Young Lee; Long Li; Richard J Kuhn; Michael G Rossmann; John D Morrey; Young-Min Lee
Journal:  PLoS Pathog       Date:  2014-07-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.